These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 672629)

  • 21. Reconstitution of the rabbit pulmonary microsomal mixed-function oxidase system from solubilized components.
    Philpot RM; Arinc E; Fouts JR
    Drug Metab Dispos; 1975; 3(2):118-26. PubMed ID: 236158
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sex differences in cytochrome P-450 and mixed-function oxygenase activity in gonadally mature trout.
    Stegeman JJ; Chevion M
    Biochem Pharmacol; 1980 Feb; 29(4):553-8. PubMed ID: 6768363
    [No Abstract]   [Full Text] [Related]  

  • 23. Species differences of mixed-function oxidase induction between rabbits and rats after pretreatment with polychlorinated biphenyls (PCBs).
    Wolff T; Hesse S
    Biochem Pharmacol; 1977 Apr; 26(8):783-7. PubMed ID: 405014
    [No Abstract]   [Full Text] [Related]  

  • 24. Depression of hepatic cytochrome P-450-dependent mixed function oxidases during infection with encephalomyocarditis virus.
    Renton KW
    Biochem Pharmacol; 1981 Aug; 30(16):2333-6. PubMed ID: 6271141
    [No Abstract]   [Full Text] [Related]  

  • 25. Microsomal peroxidase: interrelationship with the hepatic drug metabolizing system.
    Bidlack WR
    Proc West Pharmacol Soc; 1978; 21():329-35. PubMed ID: 693516
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of storage on microsomal mixed function oxidase activity in mouse liver.
    Litterst CL; Mimnaugh EG; Reagan RL; Gram TE
    Biochem Pharmacol; 1974 Sep; 23(17):2391-4. PubMed ID: 4139954
    [No Abstract]   [Full Text] [Related]  

  • 27. On the possible in vitro use of perfluoro compounds as oxygen reservoir for the microsomal monooxygenase system.
    Brown NA; Netter KJ; Bridges JW
    Biochem Pharmacol; 1979 Sep; 28(18):2850-2. PubMed ID: 115475
    [No Abstract]   [Full Text] [Related]  

  • 28. On the participation of cytochrome P-450 in the mechanism of prevention of hepatic carcinogenesis.
    Saprin AN
    Adv Exp Med Biol; 1976; 74():314-20. PubMed ID: 183471
    [No Abstract]   [Full Text] [Related]  

  • 29. Effect of microsomal preparations and induction on cytochrome P-450-dependent monooxygenases in fetal and neonatal rat liver.
    Cresteil T; Flinois JP; Pfister A; Leroux JP
    Biochem Pharmacol; 1979 Jul; 28(13):2057-63. PubMed ID: 224884
    [No Abstract]   [Full Text] [Related]  

  • 30. Effect of protein deficiency on the hepatic microsomal mixed function oxidase. III-Influence on aflatoxin B1 metabolism and epoxide hydrase activity.
    Adekunle AA; Hayes JR; Campbell TC
    Biochem Exp Biol; 1978; 14(1):45-53. PubMed ID: 105748
    [No Abstract]   [Full Text] [Related]  

  • 31. The inhibitory effect of pyrazinamide on microsomal monooxygenase activities is related to the binding to reduced cytochrome P-450.
    Maffei Facino R; Carini M
    Pharmacol Res Commun; 1980 Jun; 12(6):523-37. PubMed ID: 7403228
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of butylated hydroxyanisole on microsomal monooxygenase and drug metabolism.
    Peng RX; Lewis KF; Yang CS
    Zhongguo Yao Li Xue Bao; 1986 Mar; 7(2):157-61. PubMed ID: 2946156
    [No Abstract]   [Full Text] [Related]  

  • 33. Acidic steroid metabolites: biosynthesis of steroid carboxylic acids by rabbit liver microsomes and the involvement of a cytochrome P450-independent mixed function oxidase system.
    Dey AC; Senciall IR
    J Steroid Biochem; 1978 Nov; 9(11):1099-104. PubMed ID: 34064
    [No Abstract]   [Full Text] [Related]  

  • 34. Metabolism of FK506, a potent immunosuppressive agent, by cytochrome P450 3A enzymes in rat, dog and human liver microsomes.
    Shiraga T; Matsuda H; Nagase K; Iwasaki K; Noda K; Yamazaki H; Shimada T; Funae Y
    Biochem Pharmacol; 1994 Feb; 47(4):727-35. PubMed ID: 7510480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Induction of the drug-metabolizing enzymes.
    Poland A
    IARC Sci Publ; 1982; (39):351-64. PubMed ID: 6818143
    [No Abstract]   [Full Text] [Related]  

  • 36. Liver microsomal cytochrome P-450 and related monooxygenase activities in genetically hyperglycemic (ob/ob and db/db) and lean streptozotocin-treated mice.
    Rouer E; Leroux JP
    Biochem Pharmacol; 1980 Jul; 29(13):1959-62. PubMed ID: 7397002
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics of the liver microsomal drug-metabolizing enzyme system of newborn rats.
    Iba MM; Soyka LF; Schulman MP
    Mol Pharmacol; 1977 Nov; 13(6):1092-104. PubMed ID: 22806
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of a hormone-supplemented medium on cytochrome P-450 content and mono-oxygenase activities of rat hepatocytes in primary culture.
    Dickins M; Peterson RE
    Biochem Pharmacol; 1980 May; 29(9):1231-8. PubMed ID: 7397008
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on hydroperoxide-dependent substrate hydroxylation by purified liver microsomal cytochrome P-450.
    Nordblom GD; White RE; Coon MJ
    Arch Biochem Biophys; 1976 Aug; 175(2):524-33. PubMed ID: 8710
    [No Abstract]   [Full Text] [Related]  

  • 40. Cobalt as a modifier of microsomal monooxgenases in mice.
    Legrum W; Stuehmeier G; Netter KJ
    Toxicol Appl Pharmacol; 1979 Apr; 48(2):195-204. PubMed ID: 573000
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.